RPL27 (Ribosomal Protein L27) is a component of the 60S large ribosomal subunit and is encoded by the RPL27 gene located on chromosome 17q. RPL27 is one of the many ribosomal proteins that have been increasingly recognized for functions beyond protein synthesis, termed "extraribosomal functions" [1][2]. These include roles in DNA repair, cell cycle regulation, apoptosis, and neuronal development. Within neurons, where protein synthesis is crucial for synaptic plasticity, memory formation, and neuronal survival, ribosomal proteins like RPL27 play critical regulatory roles. Dysregulation of ribosomal protein expression and function has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis [3][4].
| RPL27 — Ribosomal Protein L27 |
|---|
| Gene Symbol | RPL27 |
| Full Name | ribosomal protein L27 |
| Chromosomal Location | 17q21.2 |
| NCBI Gene ID | 6157 |
| OMIM | 604199 |
| Ensembl ID | ENSG00000131469 |
| UniProt ID | P61353 |
| Associated Diseases | Ribosomopathy, [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als) |
###Ribosome Structure
RPL27 is one of approximately 47 proteins that compose the eukaryotic large (60S) ribosomal subunit, alongside 3 rRNA molecules (28S, 5.8S, 5S). The ribosome catalyzes protein synthesis by:
- tRNA binding: Accommodates peptidyl-tRNA and aminoacyl-tRNA
- Peptide bond formation: Catalyzes the formation of peptide bonds
- Translocation: Moves the ribosome along the mRNA
Within the ribosome, RPL27 participates in:
- 60S subunit assembly: Component of the large subunit
- tRNA binding site: Forms part of the peptidyl transferase center
- mRNA binding: Facilitates mRNA-tRNA alignment
- Translation fidelity: Ensures accurate protein synthesis
RPL27 has been implicated in DNA repair pathways:
- p53 regulation: Interacts with p53 and modifies its activity
- DNA repair complexes: Associates with repair machinery
- Cell cycle control: Modulates cell cycle progression
- Genome stability: Maintains genomic integrity
RPL27 can modulate apoptotic pathways:
- Pro-apoptotic effects: Under certain stress conditions
- Anti-apoptotic effects: Via p53-independent pathways
- Mitochondrial regulation: Links to intrinsic apoptosis
In neurons, RPL27 has several important roles [5][6][7]:
- Local translation: Required for synaptic protein synthesis
- Synapse formation: Drosophila studies show RPL27 regulates synaptic growth
- Plasticity mechanisms: Supports activity-dependent translation
- Neurotrophin signaling: Interacts with BDNF and other factors
- Stress response: Modulates cellular stress responses
- Development: Essential for neuronal development
RPL27 is ubiquitously expressed:
- Highest: Liver, pancreas (high metabolic activity)
- Moderate: Brain, kidney, spleen
- Cellular: All proliferating cells
In the CNS, RPL27 is expressed in:
- Neurons: High expression in pyramidal neurons
- Astrocytes: Moderate expression
- Oligodendrocytes: Required for myelination
- Microglia: Lower expression
RPL27 localizes to:
- Synaptic vesicles: Present in presynaptic terminals
- Dendritic shafts: Distributed in dendrites
- Growth cones: High expression during development
- Postsynaptic densities: Supports local translation
In AD, ribosomal dysfunction is a prominent feature [14]:
- Translation impairment: Reduced protein synthesis capacity
- Ribosome availability: Fewer ribosomes available for translation
- mRNA sequestration: mRNAs trapped in defective complexes
- Synaptic protein loss: Specific vulnerability of synaptic translation
The "Ribosome Stalling Hypothesis" proposes that:
- Aberrant proteins stall ribosomes on mRNAs
- RPL27 and other proteins are dysregulated
- Synaptic proteins are particularly affected
In PD, RPL27 alterations contribute to:
- Dopaminergic neuron vulnerability: Translation deficits
- α-Synuclein translation: May alter synuclein expression
- Mitochondrial translation: Links to mitochondrial dysfunction
- Stress granules: Sequestration in stress conditions
In ALS, RPL27 is implicated in:
- Motor neuron degeneration: Translation dysregulation
- RNA granules: Sequestration in RNA granules
- Stress response: Altered stress granule dynamics
- TDP-43 pathology: Interaction with TDP-43 aggregates
Ribosomopathies are diseases caused by ribosomal protein dysfunction:
- Diamond-Blackfan anemia: RPL5, RPL11 mutations
- 5q- syndrome: RPL14, RPL5 deletions
- T-cell acute lymphoblastic leukemia: RPL10 mutations
Although RPL27 mutations are not a common cause of ribosomopathy, RPL27 dysregulation contributes to disease phenotypes.
Therapeutic strategies include:
- Translation modulators: e.g., ISRIB (integrated stress response inhibitor)
- mTOR modulators: Rapamycin, resveratrol
- Synaptic translation enhancers: Specific targets
Approaches to enhance protein synthesis:
- tRNA modifications: Target tRNA modifying enzymes
- Ribosome assembly: Enhance ribosome biogenesis
- mRNA stability: Stabilize mRNA transcripts
Managing cellular stress:
- Antioxidants: Reduce oxidative stress
- ER stress modulators: UPR modulators
- Autophagy enhancers: Clear defective components
RPL27 knockout in various models:
- Yeast: Essential for viability
- Drosophila:show developmental defects [7]
- Mice: Embryonic lethal in some backgrounds
Overexpression studies show:
- Neuroprotection: In some disease models
- Cancer association: Altered proliferation
Neuron-specific manipulation:
- Synapse formation: Altered synaptic growth
- Learning deficits:Impaired memory formation
flowchart TD
A["mRNA"] --> B["80S<br/>Ribosome"]
B --> C["Translation"]
C --> D["Protein<br/>Synthesis"]
E["RPL27"] --> F["Ribosome<br/>Biogenesis"]
F --> B
G["Stress<br/>Signals"] --> H["DNA Damage<br/>Response"]
H --> I["p53<br/>Activation"]
I --> J["Cell Cycle<br/>Arrest"]
K["Apoptosis<br/>Signals"] --> L["Mitochondrial<br/>Pathway"]
L --> M["Caspase<br/>Activation"]
M --> N["Cell Death"]
O["Neuronal<br/>Signals"] --> P["Local<br/>Translation"]
P --> Q["Synaptic<br/>Proteins"]
Q --> R["Synaptic<br/>Plasticity"]
S["Neurodegeneration"] --> T["Translation<br/>Dysregulation"]
T --> U["Ribosome<br/>Stalling"]
U --> V["Neuronal<br/>Dysfunction"]
| Partner |
Function |
| 28S rRNA |
Large subunit rRNA |
| RPL5 |
Ribosomal protein |
| RPL11 |
Ribosomal protein |
| RPL23 |
Ribosomal protein |
| Partner |
Function |
| p53 |
Tumor suppressor |
| MDM2 |
E3 ubiquitin ligase |
| c-Myc |
Transcription factor |
| eIF2α |
Translation factor |
- RPL27 expression: May serve as disease marker
- Translation capacity: Correlates with disease stage
- Therapeutic response: Target engagement
- Translation enhancement: Boost protein synthesis
- Ribosome assembly: Improve biogenesis
- Stress responses: Manage cellular stress
- Warner and McIntosh, Extraribosomal functions (2009)
- Warren et al., Ribosome biogenesis in cancer (2012)
- De Keersmaecker et al., Ribosomes translate cancer (2015)
- Khodorov et al., Protein synthesis in neurons (2002)
- Ding et al., Ribosomal proteins in neuronal survival (2005)
- Besse et al., RPL27 and synaptic growth (2011)
- Zhou et al., Functions beyond the ribosome (2015)
- Volpon et al., RPL27 in neuronal development (2018)
- Warner and McIntosh, Extraribosomal functions (2009)
- Warren et al., Ribosome biogenesis in cancer (2012)
- Teng et al., RPL5 structure (2013)
- De Keersmaecker et al., Ribosomes translate cancer (2015)
- Khodorov et al., Protein synthesis in neurons (2002)
- Ding et al., Ribosomal proteins in neuronal survival (2005)
- Besse et al., RPL27 and synaptic growth (2011)
- Zhou et al., Functions beyond the ribosome (2015)
- Volpon et al., RPL27 in neuronal development (2018)
- Kim et al., Ribosomal protein alterations (2020)
- Ma et al., RPL27 and translational control (2019)
- Chen et al., Ribosomopathies and neurodegeneration (2021)
- Liu et al., Ribosomal protein mutations (2022)
- Yang et al., Extra-ribosomal functions (2020)
- Martin et al., Translation dysregulation in AD (2023)
RPL27 contributes to ribosome biogenesis through:
- Pre-rRNA processing: Assists in rRNA processing steps
- 60S assembly: Required for proper large subunit formation
- Ribosome export: Nuclear export of 60S subunits
- Quality control: Ensures proper assembly
RPL27 modulates translation:
- Rate limiting: Can be rate-limiting for specific mRNAs
- Selective translation: Affects specific transcript classes
- Feedback control: Part of ribosome biogenesis feedback
- Stress response: Altered under stress conditions
RPL27 integrates with signaling pathways:
- mTOR pathway: Ribosome biogenesis regulation
- p53 pathway: Links DNA damage to translation
- MAPK pathway: Stress responses
- Integrin signaling: Links to cell adhesion
Multiple mechanisms link translation to neurodegeneration:
- Global translation reduction: Reduced protein synthesis
- Selective translation defects: Specific mRNA classes affected
- Ribosome pausing: Stalled translation complexes
- RNA granule formation: Pathological RNA granules
- eIF2α phosphorylation: Reduces global translation
- mTOR dysregulation: Alters ribosome assembly
- Synaptic translation: Specifically affected
- Proteostatic stress: Accumulates defective proteins
- Leucine-rich repeat kinase: Linked to translation
- Mitochondrial translation: Combined defect
- Stress granules: Sequester translation machinery
- Autophagy-translation cross-talk: Impaired protein synthesis
- RNA granules: Pathological RNP granules
- Translation initiation: Altered eIF4F complex
- Ribosome occupancy: Reduced on mRNAs
- TDP-43 pathology: Affects translation regulation
RPL27 as a potential biomarker:
- Blood levels: Easily measurable
- Disease correlation: Varies with disease stage
- Therapeutic response: Target engagement marker
Strategies targeting translation:
- Translation enhancers: Boost protein synthesis
- Ribosome modulators: Improve assembly
- Stress response: Modulate integrated stress response
- Autophagy enhancers: Clear defective components
Gene therapy for translation defects:
- RPL27 overexpression: Increase ribosomal protein levels
- Translation factor delivery: eIF4E, eIF4G delivery
- Ribosome engineering: Modified ribosomes
- mRNA therapy: mRNA-based protein expression
| Partner |
Interaction Type |
Functional Consequence |
| RPL5 |
Direct binding |
Ribosome assembly |
| RPL11 |
Direct binding |
Ribosome assembly |
| RPL23 |
Indirect |
Ribosome stability |
| RPL28 |
Co-complex |
Cofunctional |
| p53 |
Direct binding |
DNA damage response |
| MDM2 |
Indirect regulation |
p53 regulation |
| eIF4E |
Functional link |
Translation initiation |
| eIF4G |
Functional link |
Translation initiation |
RPL27 interacts with:
- 5S rRNA: Component of ribosome
- 28S rRNA: Large subunit rRNA
- 5.8S rRNA: Small subunit rRNA
- mRNA: Translated transcripts
RPL27 is highly conserved across species:
- Yeast: Essential for viability
- Drosophila: Developmental function
- Zebrafish: Development
- Mouse: Essential
- Human: Functional conservation
Model organism studies reveal:
- Drosophila RPL27: Synaptic function critical
- Zebrafish RPL27: Developmental required
- Mouse RPL27: Embryonic lethal when null
RPL27 in diagnostics:
- Disease biomarkers: Altered in neurodegeneration
- Therapeutic monitoring: Treatment response
- Disease progression: Stage correlation
Translation-targeted therapies in trials:
- ISRIB: Integrated stress response inhibitor
- eIF4E inhibitors: mTOR-independent targets
- Ribosome enhancers: Direct ribosomal protein targeting
¶ Summary and Future Directions
The field of ribosomal biology and neurodegeneration continues to evolve. Key questions remain:
- Mechanism specificity: How does RPL27 contribute specifically to neurons?
- Therapeutic targeting: Can translation be safely enhanced?
- Disease selectivity: Why are specific neurons vulnerable?
- Combination approaches: How to combine with other therapies?
Future research directions include:
- Single-cell analysis: Neuron-type specific responses
- Temporal dynamics: Time-resolved molecular studies
- Therapeutic development: Translation-enhancing drugs
- Biomarker development: Patient stratification